CPT1A and glioblastoma: CPT1A and CD47 are highly expressed in radiotherapy resistant GBM tumors, and inhibition of CPT1A can result in decreased CD47 expression and increased macrophage phagocytosis of tumor cells (Jiang et al., 2022).